Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Nivestim Filgrastim 0.12mg Solution for injection Hospira NZ Limited Hospira Zagreb d.o.o., Zagreb, Croatia Hospira Zagreb d.o.o., Prigorje Brdovecko, Croatia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Nivestim Filgrastim 0.3mg Solution for injection Hospira NZ Limited Hospira Zagreb d.o.o., Zagreb, Croatia Hospira Zagreb d.o.o., Prigorje Brdovecko, Croatia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Nivestim Filgrastim 0.48mg Solution for injection Hospira NZ Limited Hospira Zagreb d.o.o., Zagreb, Croatia Hospira Zagreb d.o.o., Prigorje Brdovecko, Croatia
|
Dated this 4th day of June 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).